Lersivirine – a new drug for HIV infection therapy

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.12, 2013-12, pp. : 1687-1694

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new drug combination therapy for treatment-naive patients with HIV-1 infection, consisting of raltegravir, emtricitabine and tenofovir disoproxil fumarate

By Clercq Erik De

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2935-2937

Informa Healthcare

Access to resources Recommend Favorite

Antiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use

By Moyle G.J.

Drugs, Vol. 55, Iss. 3, 1998-03 ,pp. : 383-404

Adis International

Access to resources Recommend Favorite

8th International Congress on Drug Therapy in HIV Infection

By Waters Laura Nelson Mark

Future Virology, Vol. 2, Iss. 2, 2007-03 ,pp. : 153-156

Future Medicine

Access to resources Recommend Favorite

Gene therapy for HIV infection

By Chadwick D.R. Lever A.M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 983-990

Informa Healthcare

Access to resources Recommend Favorite

Reversal of HIV Drug Resistance and Novel Strategies to Curb HIV Infection: The Viral Infectivity Factor Vif as a Target and Tool of Therapy

Current Drug Targets, Vol. 7, Iss. 7, 2006-07 ,pp. : 881-885

Bentham Science Publishers

Access to resources Recommend Favorite